The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

Jiwon Oh; Nathalie Arbour; Fabrizio Giuliani; Melanie Guenette; Shannon Kolind; Larry D. Lynd; Ruth Ann Marrie; Luanne M. Metz; Scott Burton Patten; Alexandre Prat; Alice Schabas; Penelope Smyth; Roger Tam; Anthony Traboulsee; V. Wee Yong

doi:10.1186/s12883-021-02447-7

Abstract

1 min read

Halting the progression of MS remains a fundamental need to improve the lives of people living with MS. Achieving this requires leveraging transdisciplinary approaches to better characterize why clinical progression occurs. CanProCo is a pioneering multi-dimensional cohort study aiming to characterize these determinants to inform the development and implementation of efficacious and effective interventions.

Related publications

Article2020

The canadian prospective cohort (CANPROCO) study to understand progression in multiple sclerosis: rationale and baseline characteristics

Jin‐Kyoung Oh, Nathalie Arbour, Francesco Giuliani, Shannon Kolind, Larry D. Lynd, Ruth Ann Marrie, L. Metz, Scott Burton Patten, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Anthony Traboulsee, Vanessa Yong

Article2024

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics

Jiwon Oh, Nathalie Arbour, Fabrizio Giuliani, Melanie Guenette, Shannon Kolind, Larry D. Lynd, Ruth Ann Marrie, Luanne M. Metz, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Anthony Traboulsee, V. Wee Yong, Scott Burton Patten

Article2005

Characterizing the Mechanisms of Progression in Multiple Sclerosis

Elliot M. Frohman, Massimo Filippi, Olaf Stüve, Stephen G. Waxman, John R. Corboy, J. Theodore Phillips, Claudia F. Lucchinetti, Jeffrey Wilken, Nitin J. Karandikar, Bernhard Hemmer, N. Monson, Jacques De Keyser, Hans‐Peter Hartung, Lawrence Steinman, Jorge R. Oksenberg, Bruce Cree, Stephen L. Hauser, Michael K. Racke

Article2024

Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy

Massimo Filippi, Laura Ferrè, Chiara Zanetta, Caterina Rizzi, Gabriella Pessina, Francesco Assogna, Maria A. Rocca

Preprint2024

Genetic variation in <i>HIF1A</i> is associated with smoldering inflammation and disease progression in Multiple Sclerosis

Antonino Giordano, Pernilla Stridh, Paolo Preziosa, Marco Pisa, Melissa Sorosina, Elisabetta Mascia, Silvia Santoro, Kaalindi Misra, Ferdinando Clarelli, Laura Ferrè, Maria Needhamsen, Ali Manouchehrinia, Miryam Cannizzaro, Thomas Moridi, Klementy Shchetynsky, Russell Ouellette, Adil Harroud, Elisabeth Hollister Sandberg, Subita Balaram Kuttikkatte, Fredrik Piehl, Lars Alfredsson, Jan Hillert, Tomas Olsson,